Bimzelx
NDC 50474-783, bimekizumab, injection, solution, from UCB, Inc..
- Product NDC
- 50474-783
- Status
- Listed
- Labeler
- UCB, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761151
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50474-783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BIMEKIZUMAB320 mg/2mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50474-783-78 | 50474078378 | 1 SYRINGE, GLASS in 1 CARTON (50474-783-78) / 2 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/26b88358-871f-4c80-9d80-b2fb16477f81
Use it
Look up 50474-783 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50474-783 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50474-783. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.